Publication | Open Access
Substituted 3-(5-Imidazo[2,1-<i>b</i>]thiazolylmethylene)-2-indolinones and Analogues: Synthesis, Cytotoxic Activity, and Study of the Mechanism of Action
74
Citations
23
References
2012
Year
Medicinal ChemistryTubulin AssemblyHeterocyclicChemoprevention StrategyMedicinePharmacological AgentCytotoxic ActivityCell CycleCancer CellsHeterocycle ChemistryAnti-cancer AgentBiomolecular EngineeringPharmacologyRadiation OncologyPharmaceutical ChemistryInhibitory ActivityCancer ResearchDrug Discovery
The synthesis of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and analogues is reported. Their cytotoxic activity was evaluated according to protocols available at the National Cancer Institute (NCI), Bethesda, MD. The action of selected compounds was examined for potential inhibition of tubulin assembly in comparison with the potent colchicine site agent combretastatin A-4. The most potent compounds also strongly and selectively inhibited the phosphorylation of the oncoprotein kinase Akt in cancer cells. The effect of the most interesting compounds was examined on the growth of HT-29 colon cancer cells. These compounds caused the cells to arrest in the G2/M phase of the cell cycle, as would be expected for inhibitors of tubulin assembly.
| Year | Citations | |
|---|---|---|
Page 1
Page 1